Drug Discovery World
FEBRUARY 22, 2024
Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative diseases. The post Informatics helps virtual biotech bring compound to clinical trial appeared first on Drug Discovery World (DDW).
Drug Discovery World
OCTOBER 4, 2022
William Erhardt , President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases. . With its recent award of $3.35 Overcoming sector challenges .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JANUARY 26, 2023
DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.
Drug Discovery World
JANUARY 23, 2023
Clinical trials revealed eight out of nine predictions were correct. We witnessed the unprecedented pace of vaccine development, fuelled by cutting-edge mRNA technology. Today, there have been efficacy readouts from large randomised controlled clinical trials for nine of our predictions – eight of which we predicted correctly.
Drug Discovery World
AUGUST 15, 2023
Although such electrophysiological systems may be more predictive of potential cardiac safety and efficacy than non-functional binding assays, many apparently attractive new drugs are still being discontinued later in development. Unexpected late-stage failures in drug development are, of course, the costliest.
Expert insights. Personalized for you.
52 
Let's personalize your content